Student interview: Rushma's research on genetic diseases
Rushma is a senior at the American Embassy School, New Delhi and was a part of our fall 2020 cohort. Her paper was a review titled "CRISPR/Cas9 Treatment of Genetic Diseases." Our program strategist, Prakriti, spoke with her about her research.
Prakriti: You did your Lumiere research paper on sickle cell anemia and gene therapy. Could you elaborate a bit more on what your specific question was and what interested you about this area?
Rushma: My research paper focuses on how genetic engineering, namely CRISPR/Cas9, can help treat genetic diseases, such as sickle cell anemia, thrombophilia, and breast cancer. I evaluated how this technology can revolutionize medicine and provide a gateway for treating monogenic disorders. I also analyzed the limitations of CRISPR and how to mitigate its harmful effects on the body. What interested me about this area was the breadth of topics I could study in the field of genetics, and especially that I could focus on emerging technology as an alternative to previously used treatments, hence increasing efficiency in healthcare.
